70/30 mix Humulin
Selected indexed studies
- Biphasic insulin aspart 30: literature review of adverse events associated with treatment. (Clin Ther, 2005) [PMID:16519039]
- Efficacy of biphasic insulin aspart in patients with type 2 diabetes. (Clin Ther, 2005) [PMID:16519038]
- Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. (Curr Med Res Opin, 2009) [PMID:19210140]
_Worker-drafted node — pending editorial review._
Connections
70/30 mix Humulin is a side effect of
Sources
- Biphasic insulin aspart 30: literature review of adverse events associated with treatment. (2005) pubmed
- Efficacy of biphasic insulin aspart in patients with type 2 diabetes. (2005) pubmed
- Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. (2009) pubmed
- Spotlight on insulin aspart in type 1 and 2 diabetes mellitus. (2003) pubmed
- Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients. (2004) pubmed
- An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes. (2009) pubmed
- A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes. (2004) pubmed
- Nondestructive Quantitative Inspection of Drug Products Using Benchtop NMR Relaxometry-the Case of NovoMix® 30. (2019) pubmed
- Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. (2004) pubmed
- Evaluation of the weight-increasing effects of biphasic analog and regular NPH insulin mixtures in patients with Type 2 diabetes mellitus. (2010) pubmed